SC Chong, R Rajah, PL Chow… - Journal of Oncology …, 2022 - journals.sagepub.com
Introduction Biosimilars confer significant cost-saving advantages and expand patients' access to biologic therapies in cancer care. In line with the increasing availability of …
Background With the increasing availability biosimilars, the role of pharmacists as drug information specialists has expanded to include promoting biosimilar acceptance among …
NA Azizam, M Hussain, E Nauenberg, WC Ang… - Plos one, 2024 - journals.plos.org
Objective In Malaysia, there is now a dearth of recommendations pertaining to the priority of biologic treatments for the effective management of psoriasis, given the multitude of …
B Kamphuis, AM Fontrier, M Haig, K Politopoulou… - 2021 - eprints.lse.ac.uk
Establishing an efficient and sustainable healthcare system with universal healthcare coverage is key in many settings, with the aim of balancing high-quality care, and …
NTM Hoang, O Fatokun, MJ Farrukh - Journal of Applied …, 2025 - japsonline.com
The availability of biosimilars has the potential to increase patient access to affordable biological treatments. However, a delay in national regulatory approval after global approval …
This report was produced by CAPRI, a nongovernmental, nonpartisan, international organization committed to enhancing global resilience and promoting innovative …